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It is well known that CD8+ T cell infiltration of tumors
is correlated with positive patient prognosis. Because of
this, many viral vaccine vectors have been created to
induce expansion and infiltration of tumor-specific
CD8+ T cells. Cytomegalovirus (CMV) is a herpes virus
that induces a persistent/latent infection for the life of
the host. It is able to drive large populations of viral-
specific T cells that are fully functional and infiltrate
most tissues. We have established that acute infection
with a recombinant murine CMV virus expressing an
altered gp100 antigen (MCMV-gp100) caused expansion
and tumor infiltration of gp100-specific CD8+ T cells,
leading to a therapeutic delay in the growth of B16 mel-
anomas in mice. Coincidentally, we observed that at
least 20% of the CD8+ tumor infiltrating lymphocytes
(TIL) were MCMV-specific. These virus-specific T cells
infiltrated tumors independently of viral replication.
Unexpectedly, T cell infiltration of tumors occurred
even in latently infected animals, long after viral replica-
tion had been controlled. Together, these data suggest
that virus-specific CD8+ T cells can become TIL, even
long after the primary infection. We were curious about
differences between tumor and virus-specific CD8+ TIL.
As expected, after acute MCMV-gp100 infection, gp100-
specific CD8+ TIL were PD-1hi and markedly dysfunc-
tional. Virus-specific CD8+ T cells were also PD-1hi in
the tumor after acute MCMV-gp100 infection, but these
cells remained fully functional. PD-1 is an activation
marker expressed on recently stimulated CD8+ T cells
and both gp100-specific and virus-specific T cells
expressed PD-1 after acute MCMV-gp100 infection. In
the circulation of tumor-bearing mice or in the absence
of a tumor, both gp100-specific and virus-specific CD8+
T cells lost PD-1 expression over time. However, PD-1hi
cells that migrated into tumors retained expression of
PD-1 regardless of specificity. Strikingly, introducing B16
tumors into MCMV-gp100 latently infected mice after
PD-1 expression was lost, resulted in PD-1 up-regulation
on and subsequent dysfunction of gp100-specific T cells
that entered the tumor, but not virus-specific T cells
found in the same tumors. Together, these data suggest
that the tumor environment sustains PD-1 expression on
recently activated CD8+ TIL independently of antigen in
the tumor, but that the presence of antigen in the tumor
drives subsequent CD8+ TIL dysfunction.
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